Geode Capital Management’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-478,208
Closed -$395K 4487
2025
Q1
$395K Buy
478,208
+16,940
+4% +$14K ﹤0.01% 3633
2024
Q4
$438K Buy
461,268
+7,768
+2% +$7.38K ﹤0.01% 3641
2024
Q3
$454K Sell
453,500
-5,788
-1% -$5.79K ﹤0.01% 3619
2024
Q2
$570K Buy
459,288
+18,063
+4% +$22.4K ﹤0.01% 3523
2024
Q1
$574K Buy
441,225
+12,703
+3% +$16.5K ﹤0.01% 3561
2023
Q4
$536K Buy
428,522
+18,205
+4% +$22.8K ﹤0.01% 3590
2023
Q3
$534K Buy
410,317
+11,605
+3% +$15.1K ﹤0.01% 3579
2023
Q2
$686K Sell
398,712
-369,887
-48% -$636K ﹤0.01% 3502
2023
Q1
$1.12M Buy
768,599
+26,087
+4% +$38.1K ﹤0.01% 3294
2022
Q4
$1.2M Buy
742,512
+6,939
+0.9% +$11.2K ﹤0.01% 3268
2022
Q3
$2.46M Sell
735,573
-11,409
-2% -$38.2K ﹤0.01% 3014
2022
Q2
$2.72M Buy
746,982
+21,559
+3% +$78.5K ﹤0.01% 3008
2022
Q1
$5.24M Sell
725,423
-3,725
-0.5% -$26.9K ﹤0.01% 2772
2021
Q4
$9.91M Buy
729,148
+3,540
+0.5% +$48.1K ﹤0.01% 2455
2021
Q3
$15.2M Buy
725,608
+254,585
+54% +$5.34M ﹤0.01% 2152
2021
Q2
$11.3M Buy
471,023
+202,103
+75% +$4.84M ﹤0.01% 2378
2021
Q1
$7.87M Buy
268,920
+17,278
+7% +$506K ﹤0.01% 2518
2020
Q4
$7.52M Buy
+251,642
New +$7.52M ﹤0.01% 2349